Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.62T
Total marketcap
$245.8B
Total volume
BTC 60.52%     ETH 7.27%
Dominance

NRBO Stock

2.36 {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
0
LOW - HIGH [24H]
0.0000 - 0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

NRBO Financial and Trading Overview

stock price 2.36
Previous Close 0.48
Open 0.5
Bid 0 x 1000
Ask 0 x 800
Day's Range 0.47 - 0.5
52 Week Range 0.47 - 63.85
Volume 139.09K
Avg. Volume 369.12K
Market Cap 13.45M
Beta (5Y Monthly) -0.77771
PE Ratio (TTM) N/A
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 6

NRBO Valuation Measures

Enterprise Value -17736992
Trailing P/E N/A
Forward P/E -0.86649126
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.6541722
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.605

Trading Information

Stock Price History

Beta (5Y Monthly) -0.77771
52-Week Change -96.10%
S&P500 52-Week Change 20.43%
52 Week High 63.85
52 Week Low 0.47
50-Day Moving Average 0.61
200-Day Moving Average 3.6

NRBO Share Statistics

Avg. Volume (3 month) 369.12K
Avg. Daily Volume (10-Days) 196.07K
Shares Outstanding 27.24M
Float 25.94M
Short Ratio 0.79
% Held by Insiders 50.47%
% Held by Institutions 5.88%
Shares Short 237.41K
Short % of Float 1.62%
Short % of Shares Outstanding 0.86%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:30

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -30.76%
Return on Equity (ttm) -84.44%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -11054000
Net Income Avi to Common (ttm) -13696000
Diluted EPS (ttm) -14.99
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 30.81M
Total Cash Per Share (mrq) 1.13
Total Debt (mrq) 0
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.867
Book Value Per Share (mrq) 0.755

Cash Flow Statement

Operating Cash Flow (ttm) -9430000
Levered Free Cash Flow (ttm) 5.03M

Profile of

Country United States
State MA
City Boston
Address 200 Berkeley Street
ZIP 02116
Phone 857 702 9600
Website https://www.neurobopharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 2

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Q&A For Stock

What is a current NRBO stock price?

NRBO stock price today per share is 2.36 .

How to purchase stock?

You can buy NRBO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is NRBO.

Which industry does the company belong to?

The industry is Biotechnology.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is 0.00000000 now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Healthcare.

NRBO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15603.26 USD
+0.1
10.08B USD 14784.03 USD 16292.28 USD 10.08B USD
NASDAQ Capital Market Composite RCMP 91.92 USD
-0.27
86.91 USD 95.14 USD
NASDAQ HealthCare IXHC 865.57 USD
-0.49
828.4 USD 890 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap